SAM
GSK icon

Strategic Asset Management’s GSK GSK Stock Holding History

Strategic Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$17K Hold
587
– – 0.03% 276
2022
Q2 		$32K Buy
587
+320
+120% +$17.7K 0.05% 211
2022
Q1 		$15K Hold
267
– – 0.02% 323
2021
Q4 		$15K Hold
267
– – 0.02% 307
2021
Q3 		$13K Buy
+267
New +$13.4K 0.02% 301

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Strategic Asset Management's GSK Position: Q3 2022 in Review

Strategic Asset Management held its GSK (GSK) position steady in Q3 2022 at 587 shares worth $17K. The position accounts for 0.03% of the portfolio, ranked #276.

Strategic Asset Management first reported a position in GSK in Q3 2021 and has held it in 5 quarters since. The position peaked at $32K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Strategic Asset Management held 587 shares of GSK worth $17K as of Q3 2022.
  • Strategic Asset Management left its GSK share count unchanged in Q3 2022.
  • GSK made up 0.03% of Strategic Asset Management's portfolio in Q3 2022, its #276 holding.
  • Strategic Asset Management first reported a position in GSK in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's GSK position peaked at $32K in Q2 2022.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.